FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367305554> ?p ?o ?g. }

• W4367305554 abstract "<h3>Objective:</h3> To review our academic multi-site stroke center experience with intravenous (IVT) and intra-arterial thrombolysis (IAT) for central retinal artery occlusion (CRAO). <h3>Background:</h3> CRAO is a subtype of acute ischemic stroke leading to severe visual loss. Conventional management is not effective and potentially harmful. 2021 American Heart Association scientific statement proposes similar time-windows for thrombolysis in CRAO and cerebral strokes (4.5hours for IVT, 6hours for IAT). <h3>Design/Methods:</h3> We retrospectively identified consecutive CRAO patients that received IVT or IAT in our academic enterprise stroke centers (1997–2022). Demographic, clinical characteristics, thrombolysis timeline, concurrent CRAO therapies, hospital complications, and follow-up visual outcomes were collected and analyzed using descriptive statistics. <h3>Results:</h3> Of 563 CRAO admissions, 20 (3.55%) received thrombolytic therapy: 13 IVT (mean age 68, range 55–82, 61.5% male, 12 alteplase and 1 tenecteplase, all embolic etiology) and 7 IAT (mean age 55, range 17–83, 85.7% male, 4 post-operative and 3 embolic). 11/20 (55%) received additional therapies (ocular massage, intraocular pressure lowering drops, diuretics, intra-arterial verapamil). 1 CRAO mimic received IVT. Median visual loss to IVT was 158 minutes (range 67–260 min). Baseline mean logMAR visual acuity (VA) was −3.11 (±1.16). 8/13 IVT had 3-month follow-up VA recorded (mean VA −2.53). 50% improved at least one Snellen line, 12.5% had VA > 20/100. 1/13 (7.6%) had intracranial hemorrhage after IVT. Median visual loss to IAT was 335 minutes (131 minutes to 20 hours). Dose range was 5–30 mg. Baseline IAT mean logMAR VA was −3.5 (±1.19). 5/7 showed VA improvement. 1/7 had profuse epistaxis after IAT. <h3>Conclusions:</h3> The management of acute CRAO in a multi-site academic stroke center remains heterogeneous, consultant specific. Most received a combination of thrombolytic and other conventional therapies, hence thrombolysis-specific outcomes could not be described. Prospective studies comparing thrombolysis and placebo are warranted to guide hyperacute CRAO practice. <b>Disclosure:</b> Dr. Alhayek has nothing to disclose. Mr. Sobczak has nothing to disclose. Miss Weinberg has nothing to disclose. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . Dr. Dumitrascu has nothing to disclose." @default.
• W4367305554 created "2023-04-29" @default.
• W4367305554 creator A5010575841 @default.
• W4367305554 creator A5025364822 @default.
• W4367305554 creator A5034553945 @default.
• W4367305554 creator A5044677663 @default.
• W4367305554 creator A5065031106 @default.
• W4367305554 date "2023-04-25" @default.
• W4367305554 modified "2023-09-26" @default.
• W4367305554 title "Thrombolytic Therapy for Non-arteritic Central Retinal Artery Occlusion in an Academic Multi-site Stroke Center (S45.010)" @default.
• W4367305554 doi "https://doi.org/10.1212/wnl.0000000000203399" @default.
• W4367305554 hasPublicationYear "2023" @default.
• W4367305554 type Work @default.
• W4367305554 citedByCount "0" @default.
• W4367305554 crossrefType "proceedings-article" @default.
• W4367305554 hasAuthorship W4367305554A5010575841 @default.
• W4367305554 hasAuthorship W4367305554A5025364822 @default.
• W4367305554 hasAuthorship W4367305554A5034553945 @default.
• W4367305554 hasAuthorship W4367305554A5044677663 @default.
• W4367305554 hasAuthorship W4367305554A5065031106 @default.
• W4367305554 hasConcept C118487528 @default.
• W4367305554 hasConcept C126322002 @default.
• W4367305554 hasConcept C127413603 @default.
• W4367305554 hasConcept C164705383 @default.
• W4367305554 hasConcept C2776449918 @default.
• W4367305554 hasConcept C2776572282 @default.
• W4367305554 hasConcept C2778257484 @default.
• W4367305554 hasConcept C2779095551 @default.
• W4367305554 hasConcept C2779581417 @default.
• W4367305554 hasConcept C2780645631 @default.
• W4367305554 hasConcept C2909817843 @default.
• W4367305554 hasConcept C42219234 @default.
• W4367305554 hasConcept C500558357 @default.
• W4367305554 hasConcept C71924100 @default.
• W4367305554 hasConcept C78519656 @default.
• W4367305554 hasConceptScore W4367305554C118487528 @default.
• W4367305554 hasConceptScore W4367305554C126322002 @default.
• W4367305554 hasConceptScore W4367305554C127413603 @default.
• W4367305554 hasConceptScore W4367305554C164705383 @default.
• W4367305554 hasConceptScore W4367305554C2776449918 @default.
• W4367305554 hasConceptScore W4367305554C2776572282 @default.
• W4367305554 hasConceptScore W4367305554C2778257484 @default.
• W4367305554 hasConceptScore W4367305554C2779095551 @default.
• W4367305554 hasConceptScore W4367305554C2779581417 @default.
• W4367305554 hasConceptScore W4367305554C2780645631 @default.
• W4367305554 hasConceptScore W4367305554C2909817843 @default.
• W4367305554 hasConceptScore W4367305554C42219234 @default.
• W4367305554 hasConceptScore W4367305554C500558357 @default.
• W4367305554 hasConceptScore W4367305554C71924100 @default.
• W4367305554 hasConceptScore W4367305554C78519656 @default.
• W4367305554 hasLocation W43673055541 @default.
• W4367305554 hasOpenAccess W4367305554 @default.
• W4367305554 hasPrimaryLocation W43673055541 @default.
• W4367305554 hasRelatedWork W2525740391 @default.
• W4367305554 hasRelatedWork W3030252198 @default.
• W4367305554 hasRelatedWork W3046854717 @default.
• W4367305554 hasRelatedWork W3172820680 @default.
• W4367305554 hasRelatedWork W3186616104 @default.
• W4367305554 hasRelatedWork W3191033586 @default.
• W4367305554 hasRelatedWork W4210600059 @default.
• W4367305554 hasRelatedWork W4286489470 @default.
• W4367305554 hasRelatedWork W4297893171 @default.
• W4367305554 hasRelatedWork W2028785689 @default.
• W4367305554 isParatext "false" @default.
• W4367305554 isRetracted "false" @default.
• W4367305554 workType "article" @default.